// App-Quantinova.ai

201 : Anxiety, occupation and functional ability at the start of treatment and EULAR response are the main predictors of work outcomes in patients with rheumatoid arthritis commencing either methotrexate or biologics

Researchers

Presenter

  • James Gwinnutt

Principal Investigators

  • Sarah Leggett

  • Mark Lunt

  • Anne Barton

  • Kimme Hyrich

  • Karen Walker-Bone

  • Suzanne Verstappen

Medical Centers

  • Arthritis Research UK Centre for Genetics and Genomics, University of Manchester, Manchester, United Kingdom

  • Arthritis Research UK Centre for Genetics and Genomics, University of Manchester, Manchester, United Kingdom

  • NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre

  • Arthritis Research UK/MRC Centre for Musculoskeletal Health and Work, The University of Southampton, Southampton, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Rheumatoid arthritis

  • Depression

  • Inflammatory Arthritis

  • Anxiety

Biomarkers

  • N/A

Drug/Treatment

  • Methotrexate

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved